Cargando…

Effectiveness and Safety of Chronic Migraine Preventive Treatments: A Systematic Literature Review

INTRODUCTION: Numerous medications are used for the preventive treatment of chronic migraine (CM), including oral treatments, onabotulinumtoxinA (onabotA; BOTOX), and calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs). Despite substantial clinical trial evidence, less is published a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blumenfeld, Andrew M., Kaur, Gavneet, Mahajan, Anadi, Shukla, Hemlata, Sommer, Katherine, Tung, Amy, Knievel, Kerry L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845441/ https://www.ncbi.nlm.nih.gov/pubmed/36417165 http://dx.doi.org/10.1007/s40122-022-00452-3

Ejemplares similares

Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review
por: Kharawala, Saifuddin, et al.
Publicado: (2022)

Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials
por: Blumenfeld, Andrew M., et al.
Publicado: (2021)

Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression
por: Mahajan, Anadi, et al.
Publicado: (2020)

Practical Insights on the Identification and Management of Patients with Chronic Migraine
por: Blumenfeld, Andrew, et al.
Publicado: (2022)

Clinician-Patient Dialogue About Preventive Chronic Migraine Treatment
por: Blumenfeld, Andrew M.
Publicado: (2020)

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
por: Blumenfeld, Andrew M., et al.
Publicado: (2018)

Combination CGRP monoclonal antibody and onabotulinumtoxinA treatment for preventive treatment in chronic migraine
por: Ailani, Jessica, et al.
Publicado: (2021)

Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans
por: Knievel, Kerry, et al.
Publicado: (2019)

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial
por: Ailani, Jessica, et al.
Publicado: (2020)

Preventing chronicity of migraine
por: Fanciullacci, M., et al.
Publicado: (2005)

Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab
por: Blumenfeld, Andrew, et al.
Publicado: (2022)

Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine
por: Blumenfeld, Andrew M., et al.
Publicado: (2015)

The Economic Burden of Lupus Nephritis: A Systematic Literature Review
por: Thompson, Juliette C., et al.
Publicado: (2021)

Vascular safety of erenumab for migraine prevention
por: Kudrow, David, et al.
Publicado: (2020)

The importance of an early onset of migraine prevention: an evidence-based, hypothesis-driven scoping literature review
por: Gottschalk, Christopher, et al.
Publicado: (2022)

Chronic migraine prevention with topiramate
por: Peres, M. F. P., et al.
Publicado: (2006)

Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi‐center study
por: Cowan, Robert P., et al.
Publicado: (2022)

Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor
por: Blumenfeld, Andrew, et al.
Publicado: (2021)

Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study
por: Winner, Paul K., et al.
Publicado: (2019)

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
por: Rothrock, John F., et al.
Publicado: (2019)

Topiramate in the prevention of pediatric migraine: literature review
por: Ferraro, Diana, et al.
Publicado: (2008)

Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice”
por: Blumenfeld, Andrew M., et al.
Publicado: (2020)

Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM)
por: Lipton, Richard B, et al.
Publicado: (2015)

Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study
por: Silberstein, Stephen, et al.
Publicado: (2020)

Zonisamide is effective in the preventive therapy of chronic migraine
por: Belvis, R, et al.
Publicado: (2013)

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug–drug interaction study
por: Jakate, Abhijeet, et al.
Publicado: (2021)

Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review
por: Burstein, Rami, et al.
Publicado: (2020)

Safety of OnabotulinumtoxinA in the [management of] chronic migraine in pregnancy
por: Smirnoff, Liza
Publicado: (2022)

Review of Prevention for Pediatric and Adolescent Migraine
por: Qubty, William, et al.
Publicado: (2016)

Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
por: Naegel, Steffen, et al.
Publicado: (2010)

Topiramate: Safety and Efficacy of its Use in the Prevention and Treatment of Migraine
por: Minton, Ginger C., et al.
Publicado: (2011)

Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
por: Mechtler, Laszlo, et al.
Publicado: (2022)

The Unmet Needs in the Management of Vulvar Cancer and a Review of Indian Literature
por: Kaur, Satinder, et al.
Publicado: (2022)

Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
por: Mannix, Sally, et al.
Publicado: (2016)

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
por: Frampton, James E., et al.
Publicado: (2018)

Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis
por: Zhao, Xiuyuan, et al.
Publicado: (2020)

Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study
por: Kollewe, Katja, et al.
Publicado: (2021)

Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
por: Lipton, Richard B., et al.
Publicado: (2020)

Challenges With the Use of Digital Sham: Systematic Review and Recommendations
por: Bos, Ernst, et al.
Publicado: (2023)

Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review
por: Martin, Vincent, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cvsr5fsr28jd88m4f3696bduqs